Æther Laboratories
[ Document Reference: AETHER-BPC1 ]
Compound Record // Body Protection Compound 157 (Pentadecapeptide)
BPC-157 · Pentadecapeptide Fragment
Body Protection Compound 157 (Pentadecapeptide)
A synthetic 15-amino-acid pentadecapeptide derived from a gastric protective protein sequence, supplied to qualified laboratory researchers for in-vitro study. CAS 137525-51-0.
$75/ 10mg vial
5+ vials: 10% off / 10+ vials: 15% off
Same compound only, applied automatically in cart.
Research Use Only. Not for human or veterinary consumption.
BPC‑157
CAS 137525‑51‑0| Batch ID | Test Date | Lab | Net Content | Assay Purity | Aggregate | Endotoxin | Heavy Metals | Sterility | Certificate |
|---|---|---|---|---|---|---|---|---|---|
| BPC‑260821 | 24 SEP 2026 | JANOSHIK | 11.30 MG | 99.879% | — | 1.594 EU/VIAL | Not Detected | Passed | View Certificate |
Compound Overview
Body Protection Compound 157 (Pentadecapeptide), laboratory-designated BPC-157, is a synthetic pentadecapeptide consisting of a stable chain of 15 amino acids, structurally derived from a partial sequence of a naturally occurring gastric protective protein. Extensively studied within molecular biology and cellular signaling networks, this compound serves as a reference peptide in laboratory models evaluating cellular communication and extracellular scaffold remodeling. Researchers utilize this compound in controlled in vitro frameworks to analyze its localized regulatory role without confounding systemic biological interferences.
Technical Specifications
| Product Name | Body Protection Compound 157 (BPC‑157) |
| CAS Number | 137525‑51‑0 |
| Other Names | BPC157, BPC 157, Bepecin, PL‑14736, PL‑10 |
| IUPAC Name | glycyl‑L‑alpha‑glutamyl‑L‑prolyl‑L‑prolyl‑L‑prolylglycyl‑L‑lysyl‑L‑prolyl‑L‑alanyl‑L‑alpha‑aspartyl‑L‑alpha‑aspartyl‑L‑alanylglycyl‑L‑leucyl‑L‑valine |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | 1419.56 g/mol |
| Chemical Class | Synthetic Pentadecapeptide / Gastric Juice Peptide Fragment |
Storage & Handling Guidelines
To prevent premature degradation of the peptide bonds and ensure absolute baseline reproducibility across analytical workflows, adhere to the following protocols:
Storage Conditions
Store at −20°C, desiccated, in the original sealed vial. Lyophilized peptide is stable under these conditions for the shelf life stated on its Certificate of Analysis; avoid repeated freeze‑thaw cycling and exposure to ambient humidity once opened.
Atmospheric Separation
Store the target chemical exclusively inside its original, tightly sealed containment unit, completely isolated from ambient humidity, moisture, and localized airflow.
Photolytic Barriers
Protect the compound from direct light and UV exposure by keeping it inside opaque or amber laboratory vessels.
Analytical Auditing
Aether Laboratories implements a strict dual-method verification protocol, combining High-Performance Liquid Chromatography (HPLC) with CHN elemental analysis to independently audit the net mass and absolute purity of our research compounds.
Research Use Only Disclaimer
This product is distributed and sold strictly as a Research Use Only (RUO) compound intended exclusively for in vitro laboratory evaluation and academic investigation. It is not an FDA-approved drug, licensed medication, dietary supplement, or cosmetic agent, and is strictly prohibited for human or veterinary consumption. Improper use of laboratory reference materials can present significant biological hazards. Aether Laboratories supplies these materials exclusively to qualified scientific institutions and professional investigators.